Intrinsiqs

Is Iambic Therapeutics Inc. overvalued?

Iambic Therapeutics Inc. (IAM) — key valuation metrics and fundamentals.

No verdict
Price
$13.10
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$122.8M
Dividend yield
0.0%
Return on equity
—
Sector
Healthcare

See the full interactive analysis →

Fair value compares IAM's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.